PET imaging for GPC3 in liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests a new PET imaging method that targets GPC3, a protein often found in liver cancer cells. It may help doctors see and understand liver cancer better, especially in people with newly diagnosed or recurrent disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with or are strongly suspected of having hepatocellular carcinoma (a type of liver cancer)
- You are willing to have a biopsy or a standard FDG-PET scan as part of the study
- You are not pregnant or nursing
- You have no known allergies to the GPC3 imaging agent used in this study
- Your fasting blood sugar is below 11.0 mmol/L (about 198 mg/dL) before the FDG-PET scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new PET imaging agent (GPC3-targeted) can find liver cancer as well as or better than enhanced MRI. It may help diagnose hepatocellular carcinoma (the most common type of liver cancer) more accurately.
This study tests a new imaging method that uses a special substance to find liver cancer cells. It may help doctors see if the cancer has come back after treatment, which could guide next steps.
This study tests a new imaging method (PET scan) that uses a special tracer to find prostate cancer cells, whether it's the first diagnosis or a recurrence after treatment. The goal is to see how well this imaging works for locating cancer in the body.
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
This study tests a new type of imaging agent (called a tracer) that helps PET scans see tumors more clearly. It may help doctors find and monitor cancer better.
This study tests a new way to take detailed pictures of liver cancer using a special PET/CT scan. The scan aims to help doctors see the cancer more clearly, and your results may help guide your treatment.
Hear when a new Malignant Neoplasm of Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.